Article

Isotypes may Predict Rheumatoid Arthritis

Measuring for the presence of three rheumatoid factor isotypes may increase the chance of serologically diagnosing rheumatoid arthritis, according to a study published in the Journal of Rheumatology.

Measuring for the presence of three rheumatoid factor isotypes may increase the chance of serologically diagnosing rheumatoid arthritis, according to a study published in the Journal of Rheumatology.

Researchers from the Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology in Salt Lake City analyzed serum samples from 1,021 general population patients. They examined the value of measuring RF isotypes in relation to IgG anti-cyclic citrullinated peptide (CCP) antibodies in the general population.

The results demonstrated the measuring the three isotypes of RF may increase by seven- to 21-fold the chance of making the serologic diagnosis of RA.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.